PISCATAWAY, N.J.– Camber Pharmaceuticals announces the addition of efavirenz, emtricitabine and eenofovir disoproxil fumarate tablets to their current portfolio.
Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 88 lbs.
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets from Camber are available in 600 mg/200 mg/300 mg-30 count bottles.
Comments are closed.